AI assistant
Twist Bioscience Corp — Director's Dealing 2018
Nov 21, 2018
31873_dirs_2018-11-21_3cb0fe1e-a745-46f1-acb9-ffeca7f7fe95.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2018-11-19
Reporting Person: Finn Patrick John (SVP, Commercial Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-19 | Common Stock | A | 39002 | $0.00 | Acquired | 39002 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-11-19 | Employee Stock Option (right to buy) | $26.66 | A | 91004 | Acquired | 2028-11-18 | Common Stock (91004) | Direct |
Footnotes
F1: Represents a restricted stock unit award (the "RSU Award") that vests in installments, with 12/60th of the shares subject to the RSU Award vesting on November 20, 2019 and 1/20th of the shares subject to the RSU Award vesting on each quarterly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F2: 12/60th of the shares subject to the option vest and become exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.